Search

everythinglearnresearchcommunity

for

Search:↓

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Caspases do more than kill cells; they also help in cell growth and disease, and targeting them could lead to new treatments.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

PRP growth factor concentrations vary, no significant hair growth difference found.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Adipose tissue shows promise for hair regrowth, but more research is needed to confirm best practices and effectiveness.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Liposomal carriers can improve tissue regeneration by stabilizing and retaining growth factors.

Dupilumab for skin problems might reactivate hair loss in some patients.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Dutasteride safely treats hair loss without harming sexual function.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Eating dairy and high glycemic foods may increase the risk of acne.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Men had worse COVID-19 outcomes than women in New York City.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.